Bioanalytical Service Companies
Pharma Tech Outlook
Home »Bioanalytical Services » Bioanalytical Service Companies
ChemoGenics BioPharma, LLC.: A One-stop Shop for Preclinical Drug Discovery
line

Top 10 Bioanalytical Service Companies - 2021

line

The latest bioanalytical technology innovations are setting the pace for the pharmaceutical industry as well as for biotechnology and genetic engineering. As such, bioanalysis has emerged as an essential backbone for progress in research and drug discovery. Bioanalysts, scientists, and other professionals can achieve shorter analysis and experiment times and adopt better ways to interpret measuring results with advanced bioanalytical services.

Of the many innovations in diagnostic methods, high-throughput screening is gaining immense traction. High-throughput screening is helping scientists identify biologically active substances from which they lead the development of new pharmaceuticals. Besides, mass spectrometry and microscopy, as well as immunological and molecular biology techniques, assays, and laboratory automation, are breaking new ground in the field of bioanalysis. At the same time, data management and big data continue to remain hot topics in bioanalytics while technologies like the lab-on-a-chip offer decisive contributions to drive greater efficiency.

As such, the technological transitions in the arena have opened up a universe of new possibilities for bioanalytical service companies to develop and introduce innovative services. This implies that businesses looking for competent service providers have to choose from a plethora of options.

To make this task easier and assist leaders in identifying the right bioanalytical service companies, Pharma Tech Outlook presents to you “Top 10 Bioanalytical Service Companies 2021.” A distinguished panel comprising CEOs, CIOs, VCs, Analysts, and the Pharma Tech Outlook editorial board has selected the top promising bioanalytical service companies. In our selection process, we looked at the company’s offerings, core competency, news/press releases, client testimonials, milestones, and other recognition.

    Bioanalytical Service Companies

    ChemoGenics BioPharma
    Read full profile →
    A drug discovery research and service-based organization that offers one-stop, high-quality, and economically feasible solutions for preclinical drug discovery. ... read full profile
    Frontage Laboratories
    Read full profile →
    Founded in 2001, Frontage Laboratories is a wholly-owned subsidiary of Frontage Holdings Corp (1521. HK), a global CRO driven by the mission to provide integrated, science-driven product development services from drug discovery to the late-phase clinical process. Following the vision of the parent company, Frontage Laboratories assists biopharmaceutical companies in addressing all their drug development needs, be it drug candidate evaluation, product development, or clinical services across the U.S. Frontage Laboratories' comprehensive bioanalytical services include LC-MS, Biologics bioassay, genomics services, and Biomarker services, and many more. The company has also acquired Ocean Ridge Biosciences, a genomic services provider, to expand the latter’s genomics services to a wide range of therapeutic programs ... read full profile
    PPD [NASDAQ:PPD]
    Read full profile →
    PPD [NASDAQ:PPD] serves as a market-leading contract research organization (CRO) providing bioanalytical and other clinical development services. PPD’s streamlined and cost-effective clinical development and laboratory services are proving vital for pharma clients seeking to produce and deploy life-saving drugs into the market. Whether it is peri- and post approvals or regulatory affairs, PPD supports its clients throughout their commercialization journey. As a result, the clients can focus on maintaining their market presence or commencing new market entries without having to worry about the manufacturing operations or the quality of their end products. Adding to that, the company also makes it more efficient for patients and physicians to participate in clinical trials through accelerated enrolment solutions (AES). ... read full profile
    BioAgilytix
    BioAgilytix is a bioanalytical laboratory that focuses on immunoassays and cell-based tests. Our increasing team of highly motivated employees is driven by the ambition to help the discovery of revolutionary pharmaceuticals and other scientific advances. It is based in Research Triangle Park, North Carolina. Users are able to continually surpass the clients' expectations by hiring highly experienced scientists with deep, focused knowledge in an exciting work environment.
    Celerion
    Celerion provides Applied Translational Medicine as a pioneer in early clinical research. Celerion's focus is on deploying novel methodologies to provide critical data early in the drug development process, allowing for go/no-go choices. Celerion delivers one of the most experienced clinical pharmacology research networks in the business, with a huge clinical capacity of more than 600 beds (24 in-hospital), efficient bioanalytical facilities, and skilled scientific personnel.
    ICON
    ICON is a worldwide leader in healthcare intelligence and clinical research. The company moves clinical research from molecule to medication by delivering outsourced development and commercialization services to pharmaceutical, biotechnology, government, medical device, and public health organizations. In addition, the company specializes in the strategic creation, management, and analysis of programs that support clinical development, ranging from compound selection to Phase I-IV clinical trials. As a result, the company creates breakthrough ideas, advances in developing medicines, and enhances patients' lives. ICON, headquartered in Dublin, Ireland, employs.
    Labcorp
    Labcorp is a global leader in life sciences, devoted to leveraging research to enhance health and life. The company is a go-to user source for reliable information about innovation, research, and collaboration. Managed care organizations, biopharmaceutical companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories are the groups that the company serves.
    Resilience
    Resilience offers complete biopharmaceutical production and development services. Resilience is establishing a one-of-a-kind environment for sophisticated biopharmaceutical production. They provide high-tech, end-to-end manufacturing and development solutions to ensure that today's and tomorrow's medicines can be manufactured rapidly, safely, and at scale. Resilience provides tailored and scalable procedures for complicated and new medicines, the best quality and regulatory capabilities, and world-class expertise and facilities. Cell and gene treatments, viral vectors, vaccinations, proteins, and fresh discoveries are examples of this.
    Syneos Health
    Syneos Health® (Nasdaq: SYNH) is the only business that provides fully integrated biopharmaceutical solutions. The Company, which includes a Contract Research Organization (CRO) and a Contract Commercial Organization (CCO), is designed to improve client performance in response to contemporary market realities. The Company brings together about 24,000 clinical and commercial talents to help customers in over 110 countries. They share insights, leverage cutting-edge technology, and employ modern business processes to help clients quickly provide critical medicines to patients.
    Xyzagen
    Xyzagen specializes in small molecule LC-MS/MS bioanalysis in nonclinical settings. Xyzagen assists therapeutic prospects from compound screening through preclinical development and may transfer its methodology to GLP laboratories with which its consultants have already worked or to the client's chosen suppliers. Company internal personnel and consultants can collaborate to guarantee the successful transfer of a certified technician. As the program advances and new metabolites are identified, they can efficiently review and update bioanalytical methods and assess systemic exposure to new metabolites.